181 related articles for article (PubMed ID: 37170791)
21. Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis.
Hu W; Xin Y; He Z; Zhao Y
Brain Behav; 2018 Oct; 8(10):e01115. PubMed ID: 30240176
[TBL] [Abstract][Full Text] [Related]
22. Autologous Hematopoietic Stem Cell Transplantation for Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Masson-Roy J; Breiner A; Warman-Chardon J; Pringle CE; Allan D; Bredeson C; Huebsch L; Kekre N; Kennah ML; Martin L; McDiarmid S; Altouri S; Atkins H; Bourque PR
Can J Neurol Sci; 2021 Nov; 48(6):760-766. PubMed ID: 33631093
[TBL] [Abstract][Full Text] [Related]
23. Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.
Press R; Askmark H; Svenningsson A; Andersen O; Axelson HW; Strömberg U; Wahlin A; Isaksson C; Johansson JE; Hägglund H
J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):618-24. PubMed ID: 24262917
[TBL] [Abstract][Full Text] [Related]
24. Cyclophosphamide for Treatment of Refractory Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-analysis.
Xiang Q; Cao Y; Song Z; Chen H; Hu Z; Zhou S; Zhang Y; Cui H; Luo J; Qiang Y; Wang Y; Shuai S; Yang Y; Yang M; Wei X; Xiong A
Clin Ther; 2022 Aug; 44(8):1058-1070. PubMed ID: 35872028
[TBL] [Abstract][Full Text] [Related]
25. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
Eftimov F; Winer JB; Vermeulen M; de Haan R; van Schaik IN
Cochrane Database Syst Rev; 2009 Jan; (1):CD001797. PubMed ID: 19160200
[TBL] [Abstract][Full Text] [Related]
26. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
Van Schaik IN; Winer JB; De Haan R; Vermeulen M
Cochrane Database Syst Rev; 2002; (2):CD001797. PubMed ID: 12076423
[TBL] [Abstract][Full Text] [Related]
27. Chronic inflammatory demyelinating polyneuropathy and pregnancy: systematic review.
Kohle F; Kuwabara S; Lehmann HC
J Neurol Neurosurg Psychiatry; 2021 May; 92(5):473-478. PubMed ID: 33563801
[TBL] [Abstract][Full Text] [Related]
28. Chronic inflammatory demyelinating polyneuropathy: Plasmapheresis or cyclosporine can be good treatment options in refractory cases.
Kim W; Shim YK; Choi SA; Kim SY; Kim H; Lim BC; Hwang H; Choi J; Kim KJ; Chae JH
Neuromuscul Disord; 2019 Sep; 29(9):684-692. PubMed ID: 31473049
[TBL] [Abstract][Full Text] [Related]
29. Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand.
Bamrungsawad N; Upakdee N; Pratoomsoot C; Sruamsiri R; Dilokthornsakul P; Dechanont S; Wu DB; Dejthevaporn C; Chaiyakunapruk N
Clin Drug Investig; 2016 Jul; 36(7):557-66. PubMed ID: 27113227
[TBL] [Abstract][Full Text] [Related]
30. Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health.
Ryan M; Ryan SJ
Am J Manag Care; 2018 Sep; 24(17 Suppl):S371-S379. PubMed ID: 30312032
[TBL] [Abstract][Full Text] [Related]
31. Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach.
Stino AM; Naddaf E; Dyck PJ; Dyck PJB
Muscle Nerve; 2021 Feb; 63(2):157-169. PubMed ID: 32914902
[TBL] [Abstract][Full Text] [Related]
32. Treatment of chronic inflammatory demyelinating polyneuropathy.
Kleyman I; Brannagan TH
Curr Neurol Neurosci Rep; 2015 Jul; 15(7):47. PubMed ID: 26008811
[TBL] [Abstract][Full Text] [Related]
33. Are the treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) effective and safe? - A Cochrane Overview summary with commentary.
Oaklander AL; Gimigliano F
NeuroRehabilitation; 2019; 44(4):609-612. PubMed ID: 31256085
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy.
Lucke IM; Wieske L; van der Kooi AJ; van Schaik IN; Eftimov F; Verhamme C
J Peripher Nerv Syst; 2019 Jun; 24(2):174-179. PubMed ID: 31090121
[TBL] [Abstract][Full Text] [Related]
35. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
Joint Task Force of the EFNS and the PNS
J Peripher Nerv Syst; 2005 Sep; 10(3):220-8. PubMed ID: 16221283
[TBL] [Abstract][Full Text] [Related]
36. [Treatment options for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
Kuntzer T
Rev Neurol (Paris); 2006 Apr; 162(4):539-43. PubMed ID: 16585918
[TBL] [Abstract][Full Text] [Related]
37. Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K; van Doorn PA
Drugs; 2009 May; 69(8):987-1001. PubMed ID: 19496628
[TBL] [Abstract][Full Text] [Related]
38. Chronic inflammatory demyelinating polyneuropathy.
Lewis RA
Curr Opin Neurol; 2017 Oct; 30(5):508-512. PubMed ID: 28763304
[TBL] [Abstract][Full Text] [Related]
39. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.
RMC Trial Group
Lancet Neurol; 2009 Feb; 8(2):158-64. PubMed ID: 19136303
[TBL] [Abstract][Full Text] [Related]
40. [Chronic inflammatory demyelinating polyneuropathy: Diagnosis and therapeutic update].
Franques J
Rev Med Interne; 2019 Dec; 40(12):808-815. PubMed ID: 31677862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]